Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wolff

Showing results (671-680 of 831) with videos related to

Pageof 84
Sort By:
Breast Cancer Research and Treatment|February 9, 2018
First international TNBC conference meeting reportPadmashree Rida, Angela Ogden, Ian O Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2018
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused UpdateNeelima Denduluri, Mariana Chavez-MacGregor, Melinda L Telli, et al.
Journal of Patient-Reported Outcomes|February 5, 2022
To share or not to share: communication of caregiver-reported outcomes when a patient has colorectal cancerA Fuchsia Howard, María-José Torrejón, Kelsey Lynch, et al.
Breast Cancer Research and Treatment|May 29, 2019
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trialMatteo Lambertini, Christine Campbell, Richard D Gelber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199Sylvia Adams, Robert J Gray, Sandra Demaria, et al.
Clinical Breast Cancer|January 25, 2022
Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair GenesElaine M Walsh, Neha Mangini, John Fetting, et al.
JAMA Oncology|November 6, 2015
Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast CancerChau Dang, Hao Guo, Julie Najita, et al.
Journal of Nursing Management|March 1, 2017
Starting Out: qualitative perspectives of new graduate nurses and nurse leaders on transition to practiceSandra Regan, Carol Wong, Heather K Laschinger, et al.
Journal of the American Chemical Society|October 6, 2025
Covalent Probes Reveal Small-Molecule Binding Pockets in Structured RNA and Enable Bioactive Compound DesignSandra Kovachka, Jielei Wang, Amirhossein Taghavi, et al.
Nature Communications|September 10, 2024
Robust poor man's Majorana zero modes using Yu-Shiba-Rusinov statesFrancesco Zatelli, David van Driel, Di Xu, et al.
Pageof 84

Showing results (671-680 of 831) with videos related to

Sort By:
Pageof 84
Breast Cancer Research and Treatment|February 9, 2018
First international TNBC conference meeting reportPadmashree Rida, Angela Ogden, Ian O Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2018
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused UpdateNeelima Denduluri, Mariana Chavez-MacGregor, Melinda L Telli, et al.
Journal of Patient-Reported Outcomes|February 5, 2022
To share or not to share: communication of caregiver-reported outcomes when a patient has colorectal cancerA Fuchsia Howard, María-José Torrejón, Kelsey Lynch, et al.
Breast Cancer Research and Treatment|May 29, 2019
Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trialMatteo Lambertini, Christine Campbell, Richard D Gelber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199Sylvia Adams, Robert J Gray, Sandra Demaria, et al.
Clinical Breast Cancer|January 25, 2022
Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair GenesElaine M Walsh, Neha Mangini, John Fetting, et al.
JAMA Oncology|November 6, 2015
Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast CancerChau Dang, Hao Guo, Julie Najita, et al.
Journal of Nursing Management|March 1, 2017
Starting Out: qualitative perspectives of new graduate nurses and nurse leaders on transition to practiceSandra Regan, Carol Wong, Heather K Laschinger, et al.
Journal of the American Chemical Society|October 6, 2025
Covalent Probes Reveal Small-Molecule Binding Pockets in Structured RNA and Enable Bioactive Compound DesignSandra Kovachka, Jielei Wang, Amirhossein Taghavi, et al.
Nature Communications|September 10, 2024
Robust poor man's Majorana zero modes using Yu-Shiba-Rusinov statesFrancesco Zatelli, David van Driel, Di Xu, et al.
Pageof 84